Table 1.
Baseline and clinical characteristics of COVID-19 patients
| Characteristics | Non-elderly patients | Elderly patients | P value |
|---|---|---|---|
| Age, years | 41 (31.5–49) | 73 (64–81) | |
| Sex | 0.201 | ||
| Men | 26 (57.8%) | 9 (39.1%) | |
| Women | 19 (42.2%) | 14 (60.9%) | |
| History of contact | 43 (95.6%) | 19 (82.6%) | 0.169 |
| Comorbidities | 23 (51.1%) | 19 (82.6%) | 0.017 |
| Hypertension | 4 (8.9%) | 10 (43.5%) | 0.003 |
| Diabetes | 5 (11.1%) | 6 (26.1%) | 0.464 |
| Cardiovascular disease | 9 (20.0%) | 13 (56.5%) | 0.005 |
| Chronic pulmonary disease | 0 (0.0%) | 5 (21.7%) | 0.003 |
| Liver disease | 6 (13.3%) | 1 (4.3%) | 0.409 |
| Chronic kidney disease | 1 (2.2%) | 3 (13.0%) | 0.109 |
| Signs and symptoms | |||
| Fever | 38 (84.4%) | 18 (78.3%) | 0.522 |
| Cough | 34 (75.6%) | 14 (60.9%) | 0.364 |
| Sputum production | 8 (17.8%) | 5 (21.7%) | 0.750 |
| Myalgia or fatigue | 4 (8.9%) | 1 (4.3%) | 0.656 |
| Dyspnoea | 3 (6.7%) | 1 (4.3%) | 1.000 |
| Chills | 3 (6.7%) | 1 (4.3%) | 0.584 |
| Temperature | 37.12 (±0.62) | 36.95 (±0.59) | 0.281 |
| Heart rate | 89.44 (±13.67) | 87.09 (±15.85) | 0.526 |
| Respiratory rate | 20.93 (±2.88) | 20.74 (±2.22) | 0.778 |